Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Patients Over 65 Years With Primary CNS Lymphoma: High-dose Methotrexate Combined With Chemo-immunotherapy Followed by Maintenance Therapy

NCT00989352 is registered in ClinicalTrials.gov with University Hospital Freiburg as lead sponsor.

NCT NCT00989352
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00989352 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Patients Over 65 Years With Primary CNS Lymphoma: High-dose Methotrexate Combined With Chemo-immunotherapy Followed by Maintenance Therapy
Lead sponsor
University Hospital Freiburg
Phase
Phase 2
Overall status
Unknown status
Start date
September 30, 2009
Completion date
September 30, 2011
Enrollment
56 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

primary non hodgkin lymphoma of the central nervous system